| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | ENGAGE BIOLOGICS INC. | 930 BRITTAN AVE | SAN CARLOS | CA | 94070-4002 | SAN MATEO | USA | R44TR005945 | Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells | 000 | 1 | NIH | 1/5/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $865,162 ) |
| | 2025 | 2025 | ENGAGE BIOLOGICS INC. | 930 BRITTAN AVE | SAN CARLOS | CA | 94070-4002 | SAN MATEO | USA | R44TR005945 | Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells | 001 | 1 | NIH | 9/12/2025 | $0 |
| | 2025 | 2025 | ENGAGE BIOLOGICS INC. | 930 BRITTAN AVE | SAN CARLOS | CA | 94070-4002 | SAN MATEO | USA | R44TR005945 | Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells | 000 | 1 | NIH | 7/31/2025 | $865,162 |
|
|
